AH5N1 Influenza Virus

objectives: Evaluation of the immunogenicity of IVACFLU-A / H5N1 vaccine produced by the Institute of Vaccines and Medical Biologicals at a dose of 15mcg. Evaluation of the safety of IVACFLU-A / H5N1 vaccine produced by the Institute of Vaccines and Medical Biologicals at a dose of 15mcg.

31p extraenglish 24-05-2021 19 3   Download